Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $4.17 and traded as low as $3.84. Evotec shares last traded at $4.03, with a volume of 153,406 shares.
Evotec Price Performance
The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 2.50. The firm has a market cap of $1.33 billion, a price-to-earnings ratio of 9.83 and a beta of 0.98. The stock has a 50-day moving average price of $3.70 and a 200 day moving average price of $4.17.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
- Five stocks we like better than Evotec
- EV Stocks and How to Profit from Them
- Pfizer’s 7.5% Dividend: Income Haven or House of Cards?
- Want to Profit on the Downtrend? Downtrends, Explained.
- 3 Trades Members of Congress Are Making Right Now
- High Flyers: 3 Natural Gas Stocks for March 2022
- TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
